Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer's Disease in Relation to Therapeutic Editing Tools.

Pharmaceutics · 2022 · PMC9228826 · PMID 35745842

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

hugely significantno p-value reported

Food and Drug Administration (FDA) in June 2021—on the condition of further successful trials; representing “a hugely significant milestone” in the search for AD treatments.

also in 172 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.